VIVS — VivoSim Labs Cashflow Statement
0.000.00%
- $3.17m
- $2.26m
- $0.11m
Annual cashflow statement for VivoSim Labs, fiscal year end - March 31st, USD millions except per share, conversion factor applied.
2020 March 31st | 2021 March 31st | 2022 March 31st | 2023 March 31st | 2024 March 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
Standards: | USG | USG | USG | USG | USG |
Status: | Final | Final | Final | Final | Final |
Net Income/Starting Line | -18.7 | -16.8 | -11.4 | -17.3 | -14.7 |
Depreciation | |||||
Non-Cash Items | 3.68 | 5.58 | 2.26 | 2.25 | 1.35 |
Unusual Items | |||||
Other Non-Cash Items | |||||
Changes in Working Capital | -0.998 | -2.11 | 0.597 | 2.31 | -1.62 |
Change in Accounts Receivable | |||||
Change in Inventories | |||||
Change in Prepaid Expenses | |||||
Change in Accounts Payable | |||||
Change in Accrued Expenses | |||||
Change in Other Liabilities | |||||
Cash from Operating Activities | -14.9 | -13.3 | -8.45 | -12.4 | -14.7 |
Capital Expenditures | 0 | -0.405 | -0.409 | -0.396 | -0.042 |
Purchase of Fixed Assets | |||||
Other Investing Cash Flow Items | 0.747 | 0.012 | 0 | -0.57 | 0.858 |
Sale of Fixed Assets | |||||
Sale/Maturity of Investment | |||||
Change in Net Investments | |||||
Purchase of Investments | |||||
Cash from Investing Activities | 0.747 | -0.393 | -0.409 | -0.966 | 0.816 |
Financing Cash Flow Items | -0.061 | -0.004 | -0.046 | 0 | — |
Other Financing Cash Flow | |||||
Net Issuance / Retirement of Stock | |||||
Cash from Financing Activities | 4.93 | 23.8 | 0.205 | 0 | 1.44 |
Beginning Cash Balance | |||||
Ending Cash Balance | |||||
Net Change in Cash | -9.2 | 10.1 | -8.66 | -13.4 | -12.4 |